Pamaquine
An antimalarial drug
Pamaquine | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Pamaquine, also known as plasmoquine, is an antimalarial drug belonging to the class of 8-aminoquinoline compounds. It was one of the first synthetic antimalarial agents developed and was used primarily for the treatment of Plasmodium vivax and Plasmodium ovale infections.
History[edit | edit source]
Pamaquine was synthesized in the early 20th century as part of efforts to develop effective treatments for malaria, a disease caused by Plasmodium parasites transmitted through the bites of infected Anopheles mosquitoes. It was introduced as a therapeutic agent before the discovery of more effective and less toxic alternatives such as chloroquine and primaquine.
Mechanism of Action[edit | edit source]
Pamaquine acts by interfering with the electron transport chain in the mitochondria of the malaria parasite. This disruption leads to the accumulation of toxic metabolites within the parasite, ultimately resulting in its death. Pamaquine is particularly effective against the exoerythrocytic forms of the parasite, which reside in the liver.
Pharmacokinetics[edit | edit source]
Pamaquine is administered orally and is absorbed through the gastrointestinal tract. It undergoes extensive hepatic metabolism and is excreted primarily in the urine. The drug has a relatively short half-life, necessitating frequent dosing to maintain therapeutic levels.
Side Effects[edit | edit source]
The use of pamaquine is associated with several side effects, the most notable being hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase deficiency (G6PD deficiency). Other side effects may include nausea, vomiting, and abdominal pain. Due to these adverse effects, pamaquine has largely been replaced by safer alternatives.
Current Use[edit | edit source]
While pamaquine is no longer widely used in clinical practice, it remains of historical interest as one of the pioneering antimalarial drugs. Research into its mechanism of action has contributed to the development of newer antimalarial agents.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD